Review ArticleIntegration of in Vitro Data into Allometric Scaling to Predict Hepatic Metabolic Clearance in Man: Application to 10 Extensively Metabolized Drugs
References and Notes (32)
Man versus beast: Pharmacokinetic scaling in mammals
J. Pharm. Sci.
(1986)- et al.
Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance
J. Pharm. Sci.
(1996) - et al.
A new extrapolation method from animal to man; application to a metabolized compound, mofarotene
Life Sci.
(1995) Preparation of isolated rat liver cells
Methods CellBiol.
(1976)- et al.
Comparative drug metabolism of diazepam in hepatocytes isolated from man, rat, monkey and dog
Biochem. Pharmacol.
(1989) Relevance of in vitro kinetic parameters to in vivo metabolism of xenobiotics
Toxicol. In Vitro
(1994)- et al.
Physiologically based pharmacoki-netic modeling as a tool for drug development
J. Pharmacokinet. Biopharm
(1995) Forecasting cephalosporin and monobactam antibiotic half-lives in humans from data collected in laboratory animals
Antimicrob. Agents Chemother
(1985)- et al.
Animal pharmacokinetics and interspecies scaling of FCE 22101, a penem antibiotic
J. Antimicrob. Chemother.
(1991) - et al.
Prediction of the disposition of beta-lactam antibiotics in humans from pharma-cokinetic parameters in animals
J. Pharmacokinet. Biopharm.
(1984)
Prediction of aztreonam pharma-cokinetics in humans based on data from animals
J. Pharma-cokinet. Biopharm.
(1983)
Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins
Pharm. Res.
(1991)
Interspecies pharmacokinetics of a novel hematoregulatory peptide (SK&F 107647) in rats, dogs, and oncologic patients
Pharmaceut. Res.
(1996)
Interspecies Pharmacokinetic Scaling, Biological Design and Neoteny
Interspecies scaling in pharmacokinetics
Can allometric interspecies scaling be used to predict human kinetics
Drug Inf. J.
(1994)
Cited by (166)
Predicting nonlinear relationships between external and internal concentrations with physiologically based pharmacokinetic modeling
2022, Toxicology and Applied PharmacologyNew framework for a non-animal approach adequately assures the safety of cosmetic ingredients – A case study on caffeine
2021, Regulatory Toxicology and PharmacologyPredicted values for human total clearance of a variety of typical compounds with differently humanized-liver mouse plasma data
2020, Drug Metabolism and PharmacokineticsChimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery
2018, Drug Metabolism and Pharmacokinetics3D engineered In vitro hepatospheroids for studying drug toxicity and metabolism
2017, Toxicology in Vitro
- ‡
Hautepierre Hospital, 1 Av. Moliere, 67000, Strasbourg, France.
Copyright © 1997 Wiley Liss, Inc. and the American Pharmaceutical Association. Published by Elsevier Inc. All rights reserved.